| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |